ALLERGAN INC|4May 1, 8:16 PM ET

BOYER HERBERT W PH D 4

4 · ALLERGAN INC · Filed May 1, 2013

Form 4

Period: 2013-04-29

Director

Transactions

Exercise/Conversion
Common Stock
2013-05-01+18,225→ 23,035 total
Award
Phantom Stock Units
2013-04-29$113.68/sh+13.19$1,499→ 18,190.01 total
→ Common Stock (13.19 underlying)
Award
Phantom Stock Units
2013-04-30$113.55/sh+22.02$2,500→ 18,225.22 total
→ Common Stock (22.02 underlying)
Exercise/Conversion
Phantom Stock Units
2013-05-01−18,225→ 0 total
→ Common Stock (18,225 underlying)
Award
Phantom Stock Units
2013-04-29$113.68/sh+13.19$1,499→ 18,203.2 total
→ Common Stock (13.19 underlying)

Holdings

Footnotes (6)

[F1]On May 1, 2013, 18,225 of the reporting person's Phantom Stock Units were settled for an equal number of shares of Allergan, Inc. common stock due to the reporting person's retirement as a director of Allergan, Inc. on April 30, 2013.
[F2]Includes shares acquired pursuant to dividend equivalent rights attached to RSU previously granted to the Report Person.
[F3]Shares held by the Herbert W. and Marigrace Boyer Living Trust U/A Restated August 3, 1995. Reporting person, along with his spouse, is co-trustee and co-beneficiary of the Trust.
[F4]Converts to common stock on a 1-for-1 basis.
[F5]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
[F6]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. Director.

Documents

1 file